CONTROL OF FIBROBLAST SENESCENCE AND ACTIVATION OF PROGRAMMED CELL-DEATH

被引:62
作者
WANG, E
LEE, MJ
PANDEY, S
机构
[1] MCGILL UNIV,FAC MED,DEPT MED,MONTREAL H3A 2T5,QUEBEC,CANADA
[2] MCGILL UNIV,FAC MED,DEPT ANAT,MONTREAL H3A 2T5,QUEBEC,CANADA
关键词
REPLICATIVE SENESCENCE; CELL-CYCLE TRAVERSE; PROGRAMMED CELL DEATH; APOPTOSIS; ONCOGENES AND ANTIONCOGENES;
D O I
10.1002/jcb.240540410
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have characterized a nuclear phosphoprotein of 57 kda, statin, found only in nonproliferating cells of both quiescent and senescent natures. Emerging results suggest that statin may function as a sequester to block the early G1 phase phosphorylation for the RB protein. A second protein, terminin, undergoes senescence-specific posttranslational modification from 90 to 60 kda, and further death-specific conversion from 60 to 30 kda. We also found that apoptotic mouse 3T3 fibroblasts express c-fos, c-myc, c-jun, and cdc2, as well as the upregulation of RB phosphorylation and BrdU incorporation, just before final DNA fragmentation and death. It seems that en route to death, cells re-enter the cell-cycle traverse and experience early G1 and part of S Phase; however, this cycling event is an abortive one. In contrast, senescent fibroblasts are resistant to the initiation of the death program, since they are unable to enter cell cycle traverse. Long-term serial passaging of normal human fibroblasts may be inadvertently selecting those, while termed as senescent, are also specialized survivors, and thus a good culture model to study both the control of permanent departure from cell cycle traverse and the mechanism underlying the survival or antideath cellular program. (C) 1994 Wiley-Liss, Inc.
引用
收藏
页码:432 / 439
页数:8
相关论文
共 50 条
  • [31] PROGRAMMED CELL-DEATH AT THE PERIPHERY OF THE PUPAL WING OF THE BUTTERFLY, PIERIS-RAPAE
    KODAMA, R
    YOSHIDA, A
    MITSUI, T
    ROUXS ARCHIVES OF DEVELOPMENTAL BIOLOGY, 1995, 204 (7-8): : 418 - 426
  • [32] APOPTOSIS - BCL-2 PROTEIN YIELD PROGRAMMED CELL-DEATH CLUES
    AMLING, M
    POSL, M
    BASLER, I
    DELLING, G
    PATHOLOGE, 1994, 15 (06): : 331 - 336
  • [33] ROLE OF MULTIPLE CELLULAR PROTEASES IN THE EXECUTION OF PROGRAMMED CELL-DEATH
    KUMAR, S
    HARVEY, NL
    FEBS LETTERS, 1995, 375 (03) : 169 - 173
  • [34] LOCALIZATION OF APOPTOSIS (PROGRAMMED CELL-DEATH) IN MICE BY ADMINISTRATION OF LIPOPOLYSACCHARIDE
    ZHANG, XM
    MORIKAWA, A
    TAKAHASHI, K
    JIANG, GZ
    KATO, Y
    SUGIYAMA, T
    KAWAI, M
    FUKADA, M
    YOKOCHI, T
    MICROBIOLOGY AND IMMUNOLOGY, 1994, 38 (08) : 669 - 671
  • [35] TELOMERIC ASSOCIATION OF CHROMOSOMES IS AN EARLY MANIFESTATION OF PROGRAMMED CELL-DEATH
    PATHAK, S
    RISIN, S
    BROWN, NM
    BERRY, K
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1994, 4 (02) : 323 - 328
  • [36] PROGRAMMED CELL-DEATH ENHANCES UNIFORMITY IN RAT CEREBRAL HEMISPHERES
    ZAMENHOF, S
    GUTHRIE, D
    DEVELOPMENTAL NEUROSCIENCE, 1995, 17 (04) : 264 - 266
  • [37] GLUTAMATE-INDUCED NEURONAL DEATH IS NOT A PROGRAMMED CELL-DEATH IN CEREBELLAR CULTURE
    DESSI, F
    CHARRIAUTMARLANGUE, C
    KHRESTCHATISKY, M
    BENARI, Y
    JOURNAL OF NEUROCHEMISTRY, 1993, 60 (05) : 1953 - 1955
  • [38] APOPTOSIS, PROGRAMMED CELL-DEATH IN THE CENTRAL-NERVOUS-SYSTEM
    MASLINSKA, D
    MUZYLAK, M
    FOLIA NEUROPATHOLOGICA, 1995, 33 (02): : 69 - 76
  • [39] Mechanisms and control of programmed cell death in invertebrates
    Bergmann, A
    Agapite, J
    Steller, H
    ONCOGENE, 1998, 17 (25) : 3215 - 3223
  • [40] BIOCHEMICAL-CHARACTERIZATION OF PROGRAMMED CELL-DEATH IN NGF-DEPRIVED SYMPATHETIC NEURONS
    MARTIN, DP
    ITO, A
    HORIGOME, K
    LAMPE, PA
    JOHNSON, EM
    JOURNAL OF NEUROBIOLOGY, 1992, 23 (09): : 1205 - 1220